The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to
pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

May 18, 2022

Washington and Florida reach settlements opioid defendants
On May 3 and May 5, major settlements were announced between Washington and the Wholesaler Defendants, and between Florida and Walgreens, resolving state suits arising from the opioid pandemic.

Washington and the Wholesaler Defendants
Washington State Attorney General Ferguson withdrew from the class settlement with the distributors and reportedly obtained a settlement ahead of trial of $518 million, which is estimated be nearly $100 million greater than the state would have received from the class settlement. According to news reports, McKesson will pay $197 million while AmerisourceBergen and Cardinal will pay $160.5 million each.

The settlement will not come to fruition until the various Washington political subdivisions in the suit agree by a September 2022 deadline. Settlement payments will be made over a 17-year period.

Washington remains in litigation against other defendants, including J&J. [Knauth D. Opioid distributors reach $518 mln settlement with Washington state. Reuters 2022 May 3;]

Florida and Walgreens
During a trial that began on April 11, at the conclusion of the plaintiffs’ case, Walgreens reached a settlement with the state of Florida on May 5 to pay $620 million over 18 years, plus $63 million in legal fees, according to media reports. The trial began after Walgreens declined to join a combined $878 million settlement involving 4 other defendants, including CVS. Florida has now reportedly received $1.1 billion in settlements from Walgreens and CVS, and more than $3.6 billion to date from litigation against distributors, pharmacies, and manufacturers. [Knauth D. Walgreens reaches $683 mln opioid settlement with Flroida. Reuters 2022 May 5;]